Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07517913) titled 'Cerebrospinal Fluid Kinetics of Urolithin A' on April 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Double (Participant, Outcomes Assessor).

Primary Sponsor: Amazentis SA

Condition: Healthy Adult

Intervention: Dietary Supplement: Mitopure

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: May 1, 2026

Target Sample Size: 40

Countries of Recruitment: India

To know more, visit https://clinicaltrials.gov/study/NCT07517913

Published by HT Digital Content Services with permission fr...